This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouwer, H. G. A.
Right arrow Articles by Hinrichs, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouwer, H. G. A.
Right arrow Articles by Hinrichs, D. J.

 Previous Article  |  Next Article 

Infection and Immunity, January 1999, p. 253-258, Vol. 67, No. 1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Existing Antilisterial Immunity Does Not Inhibit the Development of a Listeria monocytogenes-Specific Primary Cytotoxic T-Lymphocyte Response

H. G. Archie Bouwer,1,* Hao Shen,2 Xin Fan,2 Jeff F. Miller,3 Ronald A. Barry,1 and David J. Hinrichs1

Immunology Research, Veterans Affairs Medical Center, and Earle A. Chiles Research Institute, Portland, Oregon1; Department of Microbiology and Immunology at University of Pennsylvania Medical School, Philadelphia, Pennsylvania2; and Department of Microbiology and Immunology at UCLA, Los Angeles, California3

Received 28 July 1998/Returned for modification 6 October 1998/Accepted 28 October 1998

Infection of BALB/c mice with Listeria monocytogenes stimulates an antilisterial immune response evident by the appearance of H2-Kd-restricted CD8+ cytotoxic T lymphocytes (CTLs) specific for the nanomer peptides amino acids (aa) 91 to 99 of listeriolysin O (LLO 91-99) and aa 217 to 225 of the p60 molecule (p60 217-225). We have introduced point mutations at anchor residues within LLO 91-99 (92F) or p60 217-225 (218F), and BALB/c mice infected with L. monocytogenes strains containing these point mutations do not develop CTLs specific for LLO 91-99 or p60 217-225, respectively. We have used these strains to test whether primary CTL responses against L. monocytogenes-derived determinants can be stimulated within an environment of existing antilisterial immunity. We found that the development of a primary L. monocytogenes-specific CTL response is not altered by existing immunity to L. monocytogenes. For example, primary immunization with the p60 218F strain of L. monocytogenes followed by a secondary immunization with wild-type L. monocytogenes results in stimulation of p60 217-225-specific CTLs at primary response levels and LLO 91-99-specific effectors at levels consistent with a memory CTL response. Similarly, primary immunization with the 92F strain of L. monocytogenes followed by a secondary immunization with wild-type L. monocytogenes results in stimulation of LLO 91-99-specific CTLs at primary response levels and p60 217-225-specific effectors at levels consistent with a memory CTL response. These results provide additional support for the use of L. monocytogenes as a recombinant vaccine vector and show that antivector immunity does not inhibit the development of a primary CTL response when the epitope is delivered by L. monocytogenes as the vaccine strain.


* Corresponding author. Mailing address: Immunology Research RD21, VAMC, Portland, OR 97201. Phone: (503) 721-7840. Fax: (503) 273-5135. E-mail: bouwera{at}ohsu.edu.


Infection and Immunity, January 1999, p. 253-258, Vol. 67, No. 1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Leong, M. L., Hampl, J., Liu, W., Mathur, S., Bahjat, K. S., Luckett, W., Dubensky, T. W. Jr., Brockstedt, D. G. (2009). Impact of Preexisting Vector-Specific Immunity on Vaccine Potency: Characterization of Listeria monocytogenes-Specific Humoral and Cellular Immunity in Humans and Modeling Studies Using Recombinant Vaccines in Mice. Infect. Immun. 77: 3958-3968 [Abstract] [Full Text]  
  • Yan, L., Qiu, J., Chen, J., Ryan-Payseur, B., Huang, D., Wang, Y., Rong, L., Melton-Witt, J. A., Freitag, N. E., Chen, Z. W. (2008). Selected prfA* Mutations in Recombinant Attenuated Listeria monocytogenes Strains Augment Expression of Foreign Immunogens and Enhance Vaccine-Elicited Humoral and Cellular Immune Responses. Infect. Immun. 76: 3439-3450 [Abstract] [Full Text]  
  • Lauer, P., Hanson, B., Lemmens, E. E., Liu, W., Luckett, W. S., Leong, M. L., Allen, H. E., Skoble, J., Bahjat, K. S., Freitag, N. E., Brockstedt, D. G., Dubensky, T. W. Jr. (2008). Constitutive Activation of the PrfA Regulon Enhances the Potency of Vaccines Based on Live-Attenuated and Killed but Metabolically Active Listeria monocytogenes Strains. Infect. Immun. 76: 3742-3753 [Abstract] [Full Text]  
  • Li, Z., Zhao, X., Zhou, C., Gu, B., Frankel, F. R. (2006). A truncated Bacillus subtilis dal gene with a 3' ssrA gene tag regulates the growth and virulence of racemase-deficient Listeria monocytogenes.. Microbiology 152: 3091-3102 [Abstract] [Full Text]  
  • Zhao, X., Zhang, M., Li, Z., Frankel, F. R. (2006). Vaginal Protection and Immunity after Oral Immunization of Mice with a Novel Vaccine Strain of Listeria monocytogenes Expressing Human Immunodeficiency Virus Type 1 gag.. J. Virol. 80: 8880-8890 [Abstract] [Full Text]  
  • Kotton, C. N., Hohmann, E. L. (2004). Enteric Pathogens as Vaccine Vectors for Foreign Antigen Delivery. Infect. Immun. 72: 5535-5547 [Full Text]  
  • Starks, H., Bruhn, K. W., Shen, H., Barry, R. A., Dubensky, T. W., Brockstedt, D., Hinrichs, D. J., Higgins, D. E., Miller, J. F., Giedlin, M., Bouwer, H. G. A. (2004). Listeria monocytogenes as a Vaccine Vector: Virulence Attenuation or Existing Antivector Immunity Does Not Diminish Therapeutic Efficacy. J. Immunol. 173: 420-427 [Abstract] [Full Text]  
  • Tvinnereim, A. R., Hamilton, S. E., Harty, J. T. (2002). CD8+-T-Cell Response to Secreted and Nonsecreted Antigens Delivered by Recombinant Listeria monocytogenes during Secondary Infection. Infect. Immun. 70: 153-162 [Abstract] [Full Text]  
  • Gaillot, O., Bregenholt, S., Jaubert, F., Di Santo, J. P., Berche, P. (2001). Stress-Induced ClpP Serine Protease of Listeria monocytogenes Is Essential for Induction of Listeriolysin O-Dependent Protective Immunity. Infect. Immun. 69: 4938-4943 [Abstract] [Full Text]  
  • Bouwer, H. G. A., Barry, R. A., Hinrichs, D. J. (2001). Lack of Expansion of Major Histocompatibility Complex Class Ib-Restricted Effector Cells following Recovery from Secondary Infection with the Intracellular Pathogen Listeria monocytogenes. Infect. Immun. 69: 2286-2292 [Abstract] [Full Text]  
  • Tvinnereim, A. R., Harty, J. T. (2000). CD8+ T-Cell Priming against a Nonsecreted Listeria monocytogenes Antigen Is Independent of the Antimicrobial Activities of Gamma Interferon. Infect. Immun. 68: 2196-2204 [Abstract] [Full Text]